PharmiWeb.com - Global Pharma News & Resources
03-Jul-2019

Nasal Drug Delivery Technology Market Size to Cross USD 68.1 Billion by 2026

The Global Nasal Drug Delivery Technology Market Size is expected to reach USD 68.1 Billion by 2026 and growing CAGR around 7.3 % during the forecast period 2018 to 2026.

The Global Nasal Drug Delivery Technology Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/1057

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Nasal Drug Delivery Technology Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Nasal Drug Delivery Technology Market?
  • What is the market drivers, restrains, opportunities governing the global Nasal Drug Delivery Technology Market?
  • Which is the largest and the fastest growing segments in the global Nasal Drug Delivery Technology Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Nasal Drug Delivery Technology Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues.

The major players associated with the Nasal Drug Delivery Technology Market are NAVEH Pharma Ltd.; GlaxoSmithKline PLC; ENT Technologies Pty. Ltd.; AstraZeneca PLC; Douglas Pharmaceuticals Ltd.; Pfizer, Inc.; PendoPharm, Inc.; OptiNose, Inc.; B.F. Ascheramp; Company, Inc.; Becton, Dickinson and Company; Cadila Pharmaceuticals Ltd.; and Promius Pharma, LLC.

To Purchase this Premium Report athttps://www.acumenresearchandconsulting.com/buy-now/0/1057

The Major Market Segments of GlobalNasal Drug Delivery Technology Marketare as below:

Market Segmentation

Market By Dosage Form

  • Spray
  • Drops
  • Gel
  • Powder

Market By Container Type

  • Pressurized
  • Non-pressurized

Market By Therapeutic Application

  • Nasal Congestion
  • Rhinitis
  • Asthma
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America drove the market with an income offer of 36.41% in 2018. This development was ascribed to expanded malady pervasiveness combined with purchaser mindfulness about nasal products. As per CDC, in 2017, the quantity of grown-ups with asthma matured 18 years or more in U.S. were around 20.4 million contributing roughly 8.3% of the all-out populace in the nation. In addition, the quantity of kids under 18 years old with asthma was around 6.1 million. North America will observer stronger development throughout the following couple of years because of created economies in the region.

Asia Pacific is relied upon to witness the quickest CAGR of 7.5% in the coming years. This development is for the most part because of accessibility of viable treatment strategies, high neglected clinical requirements, rising disposable income, and expanding mindfulness about these products. Also, the nearness of key organizations in this region, for example, AptarGroup, Inc.; Sun Pharmaceutical Industries Ltd.; and Cipla Inc., is required to positively affect the general market.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Nasal Drug Delivery Technology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Nasal Drug Delivery Technology Market By Dosage Form
1.2.2.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison By Dosage Form (2015-2026)
1.2.2.2. Global Nasal Drug Delivery Technology Market Revenue Share By Dosage Form in 2017
1.2.2.3. Spray
1.2.2.4. Drops
1.2.2.5. Gel
1.2.2.6. Powder
1.2.2.7. Others
1.2.3. Nasal Drug Delivery Technology Market By Container Type
1.2.3.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison By Container Type (2015-2026)
1.2.3.2. Pressurized
1.2.3.3. Non-pressurized
1.2.3.4. Others
1.2.4. Nasal Drug Delivery Technology Market By Therapeutic Application
1.2.4.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison By Therapeutic Application (2015-2026)
1.2.4.2. Nasal Congestion
1.2.4.3. Rhinitis
1.2.4.4. Asthma
1.2.4.5. Others
1.2.5. Nasal Drug Delivery Technology Market by Geography
1.2.5.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Nasal Drug Delivery Technology Major Manufacturers in 2017

CHAPTER 4. NASAL DRUG DELIVERY TECHNOLOGY MARKET BY DOSAGE FORM

4.1. Global Nasal Drug Delivery Technology Revenue By Dosage Form
4.2. Spray
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Drops
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Gel
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Powder
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Other
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NASAL DRUG DELIVERY TECHNOLOGY MARKET BY CONTAINER TYPE

5.1. Global Nasal Drug Delivery Technology Revenue By Container Type
5.2. Pressurized
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Non-pressurized
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NASAL DRUG DELIVERY TECHNOLOGY MARKET BY THERAPEUTIC APPLICATION

6.1. Global Nasal Drug Delivery Technology Revenue By Therapeutic Application
6.2. Nasal Congestion
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Rhinitis
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Asthma
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

7.1. North America Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Nasal Drug Delivery Technology Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

8.1. Europe Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

9.1. Asia-Pacific Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

10.1. Latin America Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

11.1. Middle East Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

12.1. Africa Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. NAVEH Pharma Ltd.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. GlaxoSmithKline PLC
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. ENT Technologies Pty. Ltd.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. AstraZeneca PLC
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Douglas Pharmaceuticals Ltd.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Pfizer, Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. PendoPharm, Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. OptiNose, Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. B.F. Ascher amp; Company, Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Becton
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Dickinson and Company
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Cadila Pharmaceuticals Ltd.
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
13.13. Promius Pharma, LLC.
13.13.1. Company Snapshot
13.13.2. Overview
13.13.3. Financial Overview
13.13.4. Type Portfolio
13.13.5. Key Developments
13.13.6. Strategies
13.14. Others
13.14.1. Company Snapshot
13.14.2. Overview
13.14.3. Financial Overview
13.14.4. Type Portfolio
13.14.5. Key Developments
13.14.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1057

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 03-Jul-2019